STOCK TITAN

NEXGEL director Steven Mark Glassman buys 4,546 units

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

NEXGEL, Inc. director Steven Mark Glassman purchased 4,546 units at $5.50 per unit on November 10, 2026, in a private placement. Each unit included one common share and a warrant to buy one common share; no separate consideration was paid for the PIPE Warrant. His directly held common stock position following the transaction was 12,379 shares, including 7,833 shares held directly before the transaction after giving effect to the reverse split. No Rule 10b5-1 plan is reported.

On the same date, Glassman amended his Convertible Promissory Note and Existing Warrant: the note’s conversion price changed from $12.00 to $5.50 per share, and the warrant’s exercise price changed from $16.00 to $13.00 per share. The original securities are treated as disposed of solely for Form 4 reporting and remain outstanding as amended. The amended note converts at the contemplated merger closing or earlier at the holder’s election, subject to the Exchange Cap; its conversion price is subject to reset on the first anniversary and at maturity.

Insider glassman steven mark
Role Director
Bought 9,092 shs ($25K)
Type Security Shares Price Value
Purchase Warrant to Purchase Common Stock (the "PIPE Warrant") F1 4,546 $0.00 $0.00
Disposition Convertible Promissory Note (before amendment) F3 2,084 -- --
Grant/Award Convertible Promissory Note (as amended) F3, F4 4,546 -- --
Disposition Warrant to Purchase Common Stock F3 1,042 -- --
Grant/Award Existing Warrant (as amended) F3 1,042 -- --
Purchase Common Stock F1, F2 4,546 $5.50 $25K
Holdings After Transaction: Warrant to Purchase Common Stock (the "PIPE Warrant") — 4,546 warrants (Direct); Convertible Promissory Note (before amendment) — 0 (Direct); Convertible Promissory Note (as amended) — 4,546 (Direct); Warrant to Purchase Common Stock — 0 warrants (Direct); Existing Warrant (as amended) — 1,042 warrants (Direct); Common Stock — 12,379 shares (Direct)
Footnotes (4)
  1. F1. Reflects the Reporting Person's purchase on November 10, 2026 of 4,546 units from the Issuer, each unit consisting of one share of Common Stock and a warrant to purchase one share of Common Stock (the "PIPE Warrant"), at $5.50 per unit, in a private placement under a Securities Purchase Agreement. No separate consideration was paid for the PIPE Warrant. The closing occurred on November 10, 2026. The PIPE Warrant has an original issue date of November 10, 2026, is exercisable for cash at $10.00 per share, and expires on the fifth anniversary of its original issue date.
  2. F2. Share and underlying-share amounts reflect the 1-for-20 reverse stock split of the Issuer's common stock effective October 12, 2026. The amount beneficially owned following the reported transaction includes 7,833 shares held directly before the transaction, after giving effect to the reverse stock split.
  3. F3. On November 10, 2026, the Reporting Person entered into a Note Amendment and Conversion Agreement with the Issuer that, among other things, reduced the conversion price of his Convertible Promissory Note from $12.00 to $5.50 per share and the exercise price of his Existing Warrant from $16.00 to $13.00 per share. The amendments are reported as the disposition of the original derivative security and the acquisition of the amended derivative security. The original securities are treated as disposed of solely for purposes of this Form 4 reporting; they were amended and remain outstanding as amended. The transactions were approved in advance by the Issuer's Board of Directors on November 10, 2026 for purposes of Rule 16b-3(d) and (e). Share amounts reflect the 1-for-20 reverse stock split effective October 12, 2026. The original Note and Existing Warrant were issued on April 17, 2026.
  4. F4. The conversion price is subject to reset on the first anniversary of issuance and at maturity. The Note converts at the Issuer's closing of the contemplated merger or earlier at the holder's election, subject to the Exchange Cap.
Units purchased 4,546 units Private placement on November 10, 2026; each unit included one common share and one warrant
Unit purchase price $5.50 per unit Private placement on November 10, 2026
Common shares held following transaction 12,379 shares Directly held following the November 10, 2026 transaction
Common shares held before transaction 7,833 shares Directly held before the transaction, after giving effect to the reverse stock split
PIPE Warrant exercise price $10.00 per share Exercisable for cash; expires November 10, 2031
Note conversion price $5.50 per share Amended from $12.00 per share on November 10, 2026
Existing Warrant exercise price $13.00 per share Amended from $16.00 per share on November 10, 2026
PIPE Warrant financial
"a warrant to purchase one share of Common Stock (the “PIPE Warrant”)"
private placement financial
"in a private placement under a Securities Purchase Agreement"
A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.
Convertible Promissory Note financial
"Convertible Promissory Note from $12.00 to $5.50 per share"
A convertible promissory note is a loan a company takes now that can later be turned into shares instead of being repaid in cash. Think of it as lending money with the option to accept ownership in the business down the road; that matters to investors because it affects who gets paid first, how much ownership existing shareholders keep, and the company’s future valuation and cash needs. Terms such as conversion price, interest and maturity determine the financial impact.
Exchange Cap financial
"subject to the Exchange Cap"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NXGL units did director Steven Mark Glassman buy and at what price?

Steven Mark Glassman bought 4,546 units at $5.50 per unit on November 10, 2026, through a private placement. Each unit contained one common share and a warrant for one common share; no separate consideration was paid for the warrant. No Rule 10b5-1 plan is reported.

What are the terms of Steven Mark Glassman’s NXGL PIPE Warrant?

The PIPE Warrant is exercisable for cash at $10.00 per share and expires on November 10, 2031. It was included in the unit purchase without separate consideration.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
glassman steven mark

(Last)(First)(Middle)
C/O NEXGEL, INC. 2150 CABOT BLVD, WEST,
SUITE B

(Street)
LANGHORNE PENNSYLVANIA 19047

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
NEXGEL, INC. [ NXGL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock11/10/2026P4,546A$5.5(1)12,379(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Warrant to Purchase Common Stock (the "PIPE Warrant")(1)$1011/10/2026P4,54611/10/202611/10/2031Common Stock4,546$0.00(1)4,546D
Convertible Promissory Note (before amendment)(3)$1211/10/2026D2,08404/17/202610/17/2027Common Stock2,084(3)0D
Convertible Promissory Note (as amended)(3)(4)$5.511/10/2026A4,54604/17/202610/17/2027Common Stock4,546(3)4,546D
Warrant to Purchase Common Stock(3)$1611/10/2026D1,04204/17/202604/17/2031Common Stock1,042(3)0D
Existing Warrant (as amended)(3)$1311/10/2026A1,04204/17/202604/17/2031Common Stock1,042(3)1,042D
Explanation of Responses:
1. Reflects the Reporting Person's purchase on November 10, 2026 of 4,546 units from the Issuer, each unit consisting of one share of Common Stock and a warrant to purchase one share of Common Stock (the "PIPE Warrant"), at $5.50 per unit, in a private placement under a Securities Purchase Agreement. No separate consideration was paid for the PIPE Warrant. The closing occurred on November 10, 2026. The PIPE Warrant has an original issue date of November 10, 2026, is exercisable for cash at $10.00 per share, and expires on the fifth anniversary of its original issue date.
2. Share and underlying-share amounts reflect the 1-for-20 reverse stock split of the Issuer's common stock effective October 12, 2026. The amount beneficially owned following the reported transaction includes 7,833 shares held directly before the transaction, after giving effect to the reverse stock split.
3. On November 10, 2026, the Reporting Person entered into a Note Amendment and Conversion Agreement with the Issuer that, among other things, reduced the conversion price of his Convertible Promissory Note from $12.00 to $5.50 per share and the exercise price of his Existing Warrant from $16.00 to $13.00 per share. The amendments are reported as the disposition of the original derivative security and the acquisition of the amended derivative security. The original securities are treated as disposed of solely for purposes of this Form 4 reporting; they were amended and remain outstanding as amended. The transactions were approved in advance by the Issuer's Board of Directors on November 10, 2026 for purposes of Rule 16b-3(d) and (e). Share amounts reflect the 1-for-20 reverse stock split effective October 12, 2026. The original Note and Existing Warrant were issued on April 17, 2026.
4. The conversion price is subject to reset on the first anniversary of issuance and at maturity. The Note converts at the Issuer's closing of the contemplated merger or earlier at the holder's election, subject to the Exchange Cap.
/s/ Steven Glassman11/13/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading